In addition, the Company will continue to develop the prototype and market for its patented guidewire technology. The Company plans to attempt to develop a valid prototype and if successful conduct trials in medical clinics and/or hospitals under an FDA investigational device exemption. If positive results are obtained the Company will seek to start formal trials under an IRB approved protocol. In parallel the Company will attempt to obtain an FDA 510k for the device and select suitable manufacturers that can manufacture the device. If FDA 510k approval is obtained the Company will seek to license the related technology to strategic partners that can manufacture and/or distribute the guidewire.
News 
Market Data 
Discover 
AI
